Slings, botulinum toxin among key female urology topics

April 25, 2013

In the area of female urology, look for key studies at the AUA annual meeting involving sling surgery, onabotulinumtoxinA (Botox) injections, and reoperation after pelvic organ prolapse surgery with mesh.

This article is part of the State of Urology 2013

In the area of female urology, look for key studies at the AUA annual meeting involving sling surgery, onabotulinumtoxinA (Botox) injections, and reoperation after pelvic organ prolapse surgery with mesh.

Specifically, here are 10 can’t-miss abstracts on female urology from this year’s meeting, as selected by Shlomo Raz, MD, of UCLA:

 

559: Repeat Post-Op Voiding Trials: An Inconvenient Correlate with Success

Kimberly Ferrante

 

560: Incontinence Symptoms Following Suburethral Sling Removal

Leah Nakamura

 

561: Management of recurrent stress urinary incontinence after SISTER and TOMUS procedures

Philippe Zimmerman

 

1040: Worsening urinary storage symptoms following sling surgery in stress-incontinent women: incidence, associations, and management

Joshua P. Holstead

 

1359: Deterioration of continence after TOT when the follow-up is extended: results from a randomised controlled study

Elisabetta Costantini

 

1370: Tined lead versus percutaneous nerve evaluation for sacral nerve stimulator assessment

Julie Jenks

 

1717: Consistent and Persistent Long-term Efficacy After Repeat OnabotulinumtoxinA Detrusor Injections in Patients with Neurogenic Detrusor Overactivity

Michael Kennelly

 

1955: Comparison of baseline urologic symptoms in men and women with interstitial cystitis/bladder pain syndrome or chronic prostatitis/chronic pelvic pain syndrome

J. Quentin Clemens

 

2144: Colpocleisis: A Safe, Minimally Invasive Option for Treating Prolapse

Margaret Mueller

 

2148: Reoperation For Any Reason After Pelvic Organ Prolapse Surgery With Mesh

Jamie M. Bartley